Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study on the Safety and Effects of ATL001 and Nivolumab for Adults with Metastatic or Recurrent Melanoma
Not recruiting
Investigated Diseases:
Study on the Effectiveness and Safety of RO7198457 and Pembrolizumab for Patients with Untreated Advanced Melanoma
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on PET Tracers [18F]F-AraG and [89Zr]Zr-Df-Crefmirlimab for Evaluating T Cell Activation in Non-Small Cell Lung Cancer Patients
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with Advanced Melanoma with BRAF V600E/K Mutation
Not recruiting
Investigated Diseases:Investigated Drugs:
+5
Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with BRAF V600E/K Mutation-Positive Melanoma After Anti-PD-1 Therapy
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of LN-144 and LN-145 (Tumor Infiltrating Lymphocytes) in patients with solid tumors, including melanoma, head and neck cancer, and non-small cell lung cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on the Effectiveness and Safety of Naporafenib Combinations in Patients with Previously Treated Unresectable or Metastatic Melanoma
Not recruiting
Investigated Diseases:Investigated Drugs:
Study Comparing Ipilimumab and Nivolumab with Standard Nivolumab for Patients with Stage III Melanoma
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy
Not recruiting
Investigated Diseases:Investigated Drugs:
